Assured Pharmacy Retains ROI Group Associates As Investor Relations Counsel
Posted on: Thursday, 18 January 2007, 09:01 CST
IRVINE, Calif., Jan. 18 /PRNewswire-FirstCall/ -- Assured Pharmacy, Inc. (BULLETIN BOARD: APHY) , a specialty pharmacy providing custom services for patients with chronic pain and other long-term care conditions, announced today that it has retained ROI Group Associates, Inc. as its investor relations counsel. ROI will be executing a comprehensive investor outreach program on behalf of APHY, introducing APHY's compelling investment story to a diverse audience of potential investors.
"We have spent the past 2 years establishing a strong operational and financial foundation for Assured Pharmacy. The business model has been proven, as evidenced by our financial results, and we are poised for significant growth. We have hired ROI, as we believe our company represents a compelling investment story, and that now is the time to expand our efforts in sharing our story with potential investors," said Robert DelVecchio, CEO of Assured Pharmacy. "The chronic pain marketplace is very large, and we are seeking to establish ourselves as the quality brand in this specialty pharmacy niche. We are committed to providing exceptional customer care, which we believe is a key factor towards delivering strong long-term financial results," concluded Mr. DelVecchio.
Andrew Brown, Managing Director of ROI Group Associates, commented, "Assured Pharmacy is an exceptional growth opportunity in our opinion. The rare combination of a potentially huge, largely untapped, business opportunity, where management has made a significant financial commitment, makes us very excited about representing Assured Pharmacy. With 5 pharmacies already cash flow positive on an operational basis, Assured's business model appears to be well-established, pointing to a clear path for future growth. The sheer size of Assured's target audience, and the huge void of quality options for them to patronize, results in our belief that Assured Pharmacy is one of the best opportunities we have seen in years," concluded Mr. Brown.
Assured Pharmacy, Inc. (BULLETIN BOARD: APHY) is a specialty pharmacy providing custom services for patients with chronic pain and other long-term care conditions. The company is committed to streamlining the prescription process for doctors and patients by blending digital prescribing technology with specialized expertise in dispensing Class II controlled substances. Assured Pharmacy DME offers a complete line of durable medical equipment delivered directly to the patient's door step. Assured Pharmacy has agreements with major health plan administrators and with custom medication compounding facilities licensed by the DEA to provide controlled substances in all 50 states. Headquartered in Irvine, CA, Assured currently operates five retail locations on the west coast, with two in California (Santa Ana and Riverside), two in Oregon (both in Portland) and one in Washington (Kirkland/Seattle). Plans are underway to add additional locations in densely populated metropolitan areas. More information about Assured Pharmacy is available at http://www.assuredpharmacy.com/.
Certain statements in this news release may constitute "forward-looking" statements within the meaning of section 21E of the Securities and Exchange Act of 1934. The Company believes that its expectations, as expressed in these statements are based on reasonable assumptions regarding the risks and uncertainties inherent in achieving those expectations. These statements are not, however, guarantees of future performance and actual results may differ materially. Some of the factors that may affect the forward-looking statements in this news release are the availability of licensed personnel to operate pharmacies, the availability of suitable pharmacy locations, and the acceptance of new technologies by the medical profession. Other risk factors are listed in the most recent Annual Report on Form 10-KSB, Quarterly Report on Form 10-QSB, and most recent Registration Statement on Form SB-2 filed with the Securities and Exchange Commission. Such forward-looking statements involve risks, uncertainties, which may cause the actual results, performance, or achievement expressed or implied to differ.
Assured Pharmacy, Inc.
CONTACT: Andrew Brown of ROI Group Associates, Inc., +1-212-495-0202,abrown@roiny.com, for Assured Pharmacy, Inc.
Web site: http://www.assuredpharmacy.com/
Source: PRNewswire-FirstCall
Related Articles
- Greencore Group PLC Preliminary Statement of Results for the Year Ended September 28, 2007
- PSA HealthCare Announces Agreement to Acquire Select Pediatric Assets of The Care Group of Texas, Inc.
- Renal Care Group Announces Preliminary Results for Full Year 2005
- Fresenius Medical Care Announces Signing of Definitive Agreement to Divest Facilities in Connection With Renal Care Group Acquisition
- Renal Care Group Signs Agreement to Sell Required Facilities in Connection With Fresenius Medical Care Transaction
- Renal Care Group Shareholders Approve Merger Agreement With Fresenius Medical Care AG
- Renal Care Group Receives Subpoena From St. Louis U.S. Attorney's Office
- Gary Brukardt and Key Renal Care Group Executives to Join Fresenius Medical Care Upon Closing of the Acquisition
- Renal Care Group to Hold Special Meeting August 24, 2005
- Renal Care Group Acquires Apheresis Program
User Comments (0)

RSS Feeds